Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03863522 · ClinicalTrials.gov registry record · NA
Automated Method for Breast Cancer Detection
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Terminated
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT03863522 is a NA study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 116 participants.
The verdict
NCT03863522, a NA study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- TERMINATED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
Participants with suspicious breast lesions by mammography will undergo fine needle aspiration (FNA) under ultrasound guidance. The FNA will be read by the cytopathologist and analyzed in the breast cancer detection cartridge. All patients will receive standard of care (Ultrasound-guided core needle biopsy and diagnosis). We will also receive FNA collected from 60 patients with palpable lesions in South Africa and analyze them samples in our lab with the same method.
Interventions
- PROCEDURE Fine needle aspiration
- DEVICE Cancer Detection cartridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2019-03-07 |
| Est. Completion | 2020-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03863522
The ClinicalTrials.gov registry entry for NCT03863522 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fine needle aspiration is the first listed.
NCT03863522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03863522 about?
NCT03863522 is a clinical study titled "Automated Method for Breast Cancer Detection". Participants with suspicious breast lesions by mammography will undergo fine needle aspiration (FNA) under ultrasound guidance. The FNA will be read by the cytopathologist and analyzed in the breast cancer detection cartridge. All patients will receive standard of care (Ultrasound-guided core needle...
What is the current status of trial NCT03863522?
This trial is currently terminated. It is a NA study. The enrollment target is 116 participants. The study started on 2019-03-07. Estimated completion is 2020-12-15.
What interventions are being tested in trial NCT03863522?
The interventions under investigation include: Fine needle aspiration (PROCEDURE), Cancer Detection cartridge (DEVICE).
Who is sponsoring clinical trial NCT03863522?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.